Bylvay 200 μg

Bylvay 200 μg is a medicine authorised by Swissmedic under authorisation number 69600. The authorisation holder is IPSEN Pharma Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 December 2025 and the authorisation is limited until 03 December 2030. ATC code A05AX05 places the medicine in the group Bile and liver therapy.

  • Dispensing category B
  • Authorisation number 69600
  • ATC A05AX05
  • Synthetic medicines
Authorisation data
Authorisation number69600
NameBylvay 200 μg
Full nameBylvay 200 μg, Hartkapseln
Authorisation holderIPSEN Pharma Schweiz GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA05AX05
First authorisation04 December 2025
Authorisation validity03 December 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Bylvay 200 μg, HartkapselnB04 December 2025
2Bylvay 400 μg, HartkapselnB04 December 2025
3Bylvay 600 μg, HartkapselnB04 December 2025
4Bylvay 1200 μg, HartkapselnB04 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Kapsel(n)A05AX0504.99.0.B
230Kapsel(n)A05AX0504.99.0.B
330Kapsel(n)A05AX0504.99.0.B
430Kapsel(n)A05AX0504.99.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Bylvay 200 μg authorised in Switzerland?

Yes. Bylvay 200 μg is authorised by Swissmedic under authorisation number 69600, data as of 01 September 2026. The authorisation is limited until 03 December 2030.

Which dispensing category does Bylvay 200 μg have?

Bylvay 200 μg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Bylvay 200 μg?

The authorisation holder is IPSEN Pharma Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com